Ixazomib API is a proteasome inhibitor used in the treatment of multiple myeloma, formulated for oral administration.

Ixazomib API is manufactured and supplied by ASTANDARDS | Artis Biotech, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.